Glucosio E Potassio Cloruro Ii Galenica Senese (Potassium Chloride, Glucose Monohydrate)

Glucosio e Potassio Cloruro II Galenica Senese is indicated for several clinical situations where potassium and carbohydrate support are required.

• Treatment of hypokalemia (low blood potassium) in hospitalized patients.
• Supplementation of potassium during intravenous fluid therapy.
• Provision of an energy source during peri‑operative or critical‑care IV regimens.
• Replacement of electrolytes and calories in patients unable to take oral nutrition.
• Support of intracellular potassium shift when combined with insulin therapy.

Adverse reactions to the injection are generally related to the potassium or glucose components and may vary in frequency.

Common

• Mild vein irritation or pain at the infusion site.
• Transient hyperglycemia, especially in patients with impaired glucose tolerance.
• Slight increase in serum potassium that may cause mild muscle weakness.
• Nausea or mild gastrointestinal discomfort.
• Local swelling or edema at the injection site.
• Minor headache or dizziness.

Serious

• Severe hyperkalemia leading to cardiac arrhythmias.
• Anaphylactic or severe allergic reaction to the formulation.
• Rapid infusion causing cardiovascular overload or pulmonary edema.
• Significant hyperglycemia requiring insulin therapy.
• Metabolic acidosis in patients with renal impairment.
• Cardiac arrest due to extreme electrolyte disturbance.

Before administering Glucosio e Potassio Cloruro II Galenica Senese, clinicians should evaluate patient-specific factors and monitor relevant parameters.

• Verify serum potassium and glucose levels to avoid over‑correction.
• Adjust infusion rate in patients with renal insufficiency or heart failure.
• Use caution in individuals with diabetes mellitus or impaired glucose tolerance.
• Avoid rapid administration to reduce the risk of cardiac arrhythmias.
• Monitor cardiac rhythm and blood pressure during and after infusion.
• Consider electrolyte balance when combined with other potassium‑containing solutions.

Glucosio e Potassio Cloruro II Galenica Senese may interact with other medications that affect potassium or glucose homeostasis.

Avoid

• Concurrent use of other potassium supplements or high‑potassium IV fluids.
• Co‑administration with potassium‑sparing diuretics (e.g., spironolactone, amiloride).
• Simultaneous infusion of hypertonic glucose solutions without glucose monitoring.
• Medications that cause hyperkalemia such as trimethoprim.

Use with caution

• Insulin therapy, which can shift potassium intracellularly.
• ACE inhibitors or ARBs that may increase serum potassium.
• Beta‑blockers that can mask hypoglycemia symptoms.
• Loop diuretics that alter electrolyte balance.
• Corticosteroids that may raise blood glucose levels.
• Antidepressants that may affect electrolyte levels.